Effect of ceftaroline on normal human intestinal microflora.
about
Veterinary Medicine Needs New Green Antimicrobial DrugsGut Microbiota-brain AxisRole of cephalosporins in the era of Clostridium difficile infectionSafety profiles of old and new antimicrobials for the treatment of MRSA infections.Ceftaroline fosamil: drug profile and clinical data.Ceftaroline fosamil: a brief clinical review.Effect of liquiritin on human intestinal bacteria growth: metabolism and modulation.Ceftaroline: A New Cephalosporin with Activity against Methicillin-Resistant Staphylococcus aureus (MRSA)Ecological Effect of Ceftaroline-Avibactam on the Normal Human Intestinal MicrobiotaBiotransformation and metabolic profile of caudatin-2,6-dideoxy-3-O-methy-β-d-cymaropyranoside with human intestinal microflora by liquid chromatography quadrupole time-of-flight mass spectrometry.Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumoniaScreening of Intestinal Bacterial Metabolites of Platycodin D Using Ultra-Performance Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry.Ceftaroline fosamil: a new broad-spectrum cephalosporin.Hemarthrosis in a patient on warfarin receiving ceftaroline: a case report and brief review of cephalosporin interactions with warfarin.Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.Summary of ceftaroline fosamil clinical trial studies and clinical safety.Ceftaroline fosamil: a new cephalosporin active against resistant Gram-positive organisms including MRSA.Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections.AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics
P2860
Q26740600-A8C187CD-BD80-4FE9-953E-4A5453FE85C2Q28066767-2B9CB30E-6F69-46F8-84BC-DD6E1C0CFFA4Q28078261-F72EB939-AB12-4C70-89B8-B71D15A46ADCQ33429168-75DA7EEC-A4D4-434E-A643-BB171F0C60FCQ33772804-0C905E25-3FDC-4F4E-AEE6-CEF22B5B1C1AQ33939080-34F197E7-439B-4C77-8C36-62AF921E9CFDQ35116901-C0E1BEDC-EFEF-4B81-9252-A76461120B00Q35117981-FF7D87CD-A391-41B1-B1B5-82113E2BD1E1Q35634838-21B24CB4-9466-469C-BCD3-9206ABCF067EQ35644109-9B4A2E76-4B44-4E0B-A42A-212726F42610Q35752997-6ADA65F1-9266-4177-8709-896B0803CBDEQ36028768-2C97457A-73FE-4093-95F6-372D6441E7BEQ37863942-CA4284B1-ACA4-4551-BF66-53983F158BEAQ38024092-809D84BA-D7AA-4D04-A98E-128872DEAE06Q38025132-6FFCC3B2-EA1F-436F-AC56-6C84CA132B26Q38035807-93A2190D-A35B-4B9E-8595-CC1205B76186Q38061168-5D1C7EAE-F855-484C-AD17-3B21225206FBQ38117077-01CECC46-1992-4D1B-AB3E-925410A4F619Q38185097-019B7899-ACEC-42D5-B7EA-05CE8C9F4F09Q50916931-C5B22E19-026C-4985-9A98-22DAFB808BCFQ59135453-395EE91B-8527-4FB0-9B4F-87C2B8F32932
P2860
Effect of ceftaroline on normal human intestinal microflora.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Effect of ceftaroline on normal human intestinal microflora.
@ast
Effect of ceftaroline on normal human intestinal microflora.
@en
type
label
Effect of ceftaroline on normal human intestinal microflora.
@ast
Effect of ceftaroline on normal human intestinal microflora.
@en
prefLabel
Effect of ceftaroline on normal human intestinal microflora.
@ast
Effect of ceftaroline on normal human intestinal microflora.
@en
P2093
P2860
P356
P1476
Effect of ceftaroline on normal human intestinal microflora
@en
P2093
Alena Jandourek
Carl Erik Nord
Charlotte Asker-Hagelberg
Georgios Panagiotidis
Tobias Bäckström
P2860
P304
P356
10.1128/AAC.01716-09
P407
P577
2010-03-15T00:00:00Z